Fingerprint
Dive into the research topics of 'First-in-human trial of rhIL-15 and haploidentical natural killer cell therapy for advanced acute myeloid leukemia'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
First-in-human trial of rhIL-15 and haploidentical natural killer cell therapy for advanced acute myeloid leukemia
Sarah Cooley, Fiona He, Veronika Bachanova, Gregory M. Vercellotti, Todd E. DeFor, Julie M. Curtsinger, Paul Robertson, Bartosz Grzywacz, Kevin C. Conlon, Thomas A. Waldmann, David H. McKenna, Bruce R. Blazar, Daniel J. Weisdorf, Jeffrey S. Miller
Research output: Contribution to journal › Article › peer-review
159
Scopus
citations